Rosa & Co. is known worldwide for its PhysioPD™ Research Platforms which elucidate the connection between disease mechanisms, therapeutic interventions, and clinical outcomes.

PhysioPD Research Platforms have an extensive track record of providing credible scientific insights and actionable program impact. They deliver insights that would be difficult or impossible to achieve with any other research approach. Pharmaceutical, biotechnology, and consumer goods clients realize a significant return on investment when using PhysioPD Research for:
• Identifying responder patient populations
• Selecting predictive biomarkers
• Prioritizing or repurposing compounds
• Predicting clinical efficacy of new targets
Rosa & Co. helps clients reduce risk across their entire portfolio and its advisory capabilities are unrivaled: decades of PhysioPD-style research, hundreds of presentations and publications, and mature business processes that allow Rosa to work effectively in complex organizational or scientific settings.